Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-d]pyrimidine scaffold: evaluation of WO2013085802

By Norman Peter  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 1, 2014-01 ,pp. : 121-125

Informa Healthcare

Access to resources Recommend Favorite

Investigational Janus kinase inhibitors

By Tam Constantine S  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 687-699

Informa Healthcare

Access to resources Recommend Favorite

Design, Synthesis and Bioactivities of Phenylamino-Pyrimidine Derivatives as Novel Protein Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 7, 2011-08 ,pp. : 596-601

Bentham Science Publishers

Access to resources Recommend Favorite

N7-Substituted-5-aryl-pyrrolo[2,3-d]pyrimidines Represent a Versatile Class of Potent Inhibitors of the Tyrosine Kinase c-Src

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-06 ,pp. : 201-208

Bentham Science Publishers

Access to resources Recommend Favorite

Protein tyrosine kinase inhibitors as anticancer agents

By Supuran Claudiu T   Scozzafava Andrea  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 35-53

Informa Healthcare

Access to resources Recommend Favorite